|
|
||||||||
CUTTING EDGE |
,

*
Laboratoire dImmunologie Cellulaire, Unité Mixte de Recherche 7627, Centre National de la Recherche Scientifique Bâtiment CERVI, Hôpital Pitié-Salpétrière, Paris, France;
Unité Mixte de Recherche 146, Centre National de la Recherche Scientifique, Institut Curie, Orsay, France;
Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138;
Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada; and
¶
Theodor Kocher Institute, University of Bern, Bern, Switzerland
Based on the previous observation that RANTES mediates the cytotoxic activity of human HIV-specific CD8+ T cells via the chemokine receptor CCR3, we studied the effect of this chemokine on different effector CD8+ cytolytic cells requiring Fas/Fas ligand (FasL) or perforin-dependent pathway. In CTLs derived from PBMCs of HIV-infected patients, both the spontaneous and the RANTES-induced cytotoxicity were inhibited by anti-FasL neutralizing Abs. In contrast, allogeneic CTLs or NK cells killing through perforin were not affected by RANTES and anti-FasL Ab. Accordingly, RANTES enhanced the expression of FasL in a concentration- and time-dependent manner in HIV-specific CTLs, whereas anti-RANTES Ab decreased markedly FasL expression. Finally, cell surface expression of FasL protein in HIV-specific CTLs was also up-regulated by eotaxin, a selective ligand for CCR3. Our observations show that the action of RANTES via CCR3 is necessary to regulate FasL expression on HIV-specific CD8+ T cells that kill through the Fas/FasL pathway.
This article has been cited by other articles:
![]() |
D. Kumar, J. Hosse, C. von Toerne, E. Noessner, and P. J. Nelson JNK MAPK Pathway Regulates Constitutive Transcription of CCL5 by Human NK Cells through SP1 J. Immunol., January 15, 2009; 182(2): 1011 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Celli and P. J. Barnes Exacerbations of chronic obstructive pulmonary disease Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
R O'Donnell, D Breen, S Wilson, and R Djukanovic Inflammatory cells in the airways in COPD Thorax, May 1, 2006; 61(5): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stegelmann, M. Bastian, K. Swoboda, R. Bhat, V. Kiessler, A. M. Krensky, M. Roellinghoff, R. L. Modlin, and S. Stenger Coordinate Expression of CC Chemokine Ligand 5, Granulysin, and Perforin in CD8+ T Cells Provides a Host Defense Mechanism against Mycobacterium tuberculosis J. Immunol., December 1, 2005; 175(11): 7474 - 7483. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Winkler, P. An, and S. J. O'Brien Patterns of ethnic diversity among the genes that influence AIDS Hum. Mol. Genet., April 1, 2004; 13(90001): R9 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cappello, C. Caorsi, M. Bosticardo, S. De Angelis, F. Novelli, G. Forni, and M. Giovarelli CCL16/LEC powerfully triggers effector and antigen-presenting functions of macrophages and enhances T cell cytotoxicity J. Leukoc. Biol., January 1, 2004; 75(1): 135 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jinquan, H. H. Jacobi, C. Jing, A. Millner, E. Sten, L. Hviid, L. Anting, L. P. Ryder, C. Glue, P. S. Skov, et al. CCR3 Expression Induced by IL-2 and IL-4 Functioning as a Death Receptor for B Cells J. Immunol., August 15, 2003; 171(4): 1722 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Momma, C. N. Nagineni, M. S. Chin, K. Srinivasan, B. Detrick, and J. J. Hooks Differential Expression of Chemokines by Human Retinal Pigment Epithelial Cells Infected with Cytomegalovirus Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2026 - 2033. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walzer, A. Marcais, F. Saltel, C. Bella, P. Jurdic, and J. Marvel Cutting Edge: Immediate RANTES Secretion by Resting Memory CD8 T Cells Following Antigenic Stimulation J. Immunol., February 15, 2003; 170(4): 1615 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Musey, Y. Ding, J. Cao, J. Lee, C. Galloway, A. Yuen, K. R. Jerome, and M. J. McElrath Ontogeny and Specificities of Mucosal and Blood Human Immunodeficiency Virus Type 1-Specific CD8+ Cytotoxic T Lymphocytes J. Virol., December 16, 2002; 77(1): 291 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fernandez, M. Renedo, C. Garcia-Rodriguez, and M. Sanchez Crespo Activation of Monocytic Cells Through Fc{gamma} Receptors Induces the Expression of Macrophage-Inflammatory Protein (MIP)-1{alpha}, MIP-1{beta}, and RANTES J. Immunol., September 15, 2002; 169(6): 3321 - 3328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Locati, U. Deuschle, M. L. Massardi, F. O. Martinez, M. Sironi, S. Sozzani, T. Bartfai, and A. Mantovani Analysis of the Gene Expression Profile Activated by the CC Chemokine Ligand 5/RANTES and by Lipopolysaccharide in Human Monocytes J. Immunol., April 1, 2002; 168(7): 3557 - 3562. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cerdan, E. Devilard, L. Xerri, and D. Olive The C-class chemokine lymphotactin costimulates the apoptosis of human CD4+ T cells Blood, April 15, 2001; 97(8): 2205 - 2212. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Badley, A. A. Pilon, A. Landay, and D. H. Lynch Mechanisms of HIV-associated lymphocyte apoptosis Blood, November 1, 2000; 96(9): 2951 - 2964. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Appay, P. R. Dunbar, V. Cerundolo, A. McMichael, L. Czaplewski, and S. Rowland-Jones RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation Int. Immunol., August 1, 2000; 12(8): 1173 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado and D. Ganea Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit T Cell-Mediated Cytotoxicity by Inhibiting Fas Ligand Expression J. Immunol., July 1, 2000; 165(1): 114 - 123. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |